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INTRODUCTION
For almost a decade, the deliberative bodies and MemberStates of the European Union have been developing a newlegal framework to govern the marketing and trade of
chemicals. When adopted, the proposed regulation on
Registration, Evaluation, and Authorization of Chemicals
(“REACH”) will mark a fundamental change in the way chemi-
cals are managed in Europe and around the world. This REACH
reform process was driven by the recognition that the existing
patchwork of EU law on chemicals was inadequate to securing a
healthy environment for present and future generations. REACH
was coined in the EU Commission’s 2001 White Paper, but it
builds on years of European experience combating regional pol-
lution in the Baltic, the North Sea, the Mediterranean, the Rhine,
the Danube, and elsewhere. It now stands as the EU’s plan for
meeting the global 2020 goal to minimize the health and envi-
ronmental impacts of chemicals agreed by the governments of
the world at the World Summit on Sustainable Development in
Johannesburg in 2002. 
This White Paper’s high-minded proposal triggered a com-
plex process within the Commission to draft the legislative text
that was ultimately proposed in 2003. Economic concerns about
the competitiveness of the EU chemicals industry, as well as the
workability and transaction costs of proposed arrangements, led
EU institutions to scale back on the grander vision of REACH.
Very heavy lobbying by the chemical industry and some promi-
nent countries outside the EU forced concessions on the scope
of REACH, the duty of care, minimum data requirements, and
the consideration of alternatives.1 Intense debate within the
European Parliament and the Council has produced two critical
texts that supersede the Commission’s drafts: the result of the
Parliament’s first reading vote; and the political agreement
among the 25 Member States (the Common Position). At the
time of writing, the parliament was preparing to take up the
Council’s agreed text and consider amendments in the second
reading vote.
Despite the political influences, REACH is still guided by
some important principles. For the first time REACH places the
burden of proof on chemical makers and importers to demon-
strate the safety of their products, rather than relying on author-
ities to prove them dangerous. REACH will generate valuable
data about the properties and uses of several thousand chemicals
and mixtures, which will be available to downstream customers
and the public. REACH may drive adoption of safer substitutes
or the generation of inherently greener solutions, especially if
the Parliament’s first reading vote prevails in the final political
deal. Many countries outside Europe will feel the ripple effects
of REACH through global supply chains and evolving interna-
tional standards. Developing countries may benefit from safer
products from the EU and access to new markets for products
not requiring registration. 
This article provides an international legal perspective on
REACH. Since REACH is still under debate in the European
Parliament and the Council, this piece addresses the basic con-
tours of the likely political agreement expected in 2006, with a
special focus on the relevance of human rights and trade law.
After tracing the origins of REACH, this article explores the
role of the main EU institutions involved in the development of
the regulation. Next, this article looks at the core elements of
REACH, focusing on objectives, principles, requirements, and
impacts. An examination of some of the trade-related issues
debated at the World Trade Organization (“WTO”) sheds light
on a possible trade challenge against REACH. 
ROOTS OF THE PROBLEM: PIECEMEAL
APPROACHES TO CHEMICALS MANAGEMENT
Over the course of many years, European authorities, elect-
ed officials, industry, and civil society have concluded that the
existing EU legal framework for chemicals is unable to provide
adequate information about the impact of many chemicals on
human health and the environment. They are not alone. The
national chemical laws developed in the 1970s and later, both
inside and outside the EU, are antiquated and ineffective. At the
turn of the 21st Century the EU had managed to fully assess
approximately 140 chemicals; this nearly three decades under a
web of directives on chemical labeling, transport, and restric-
tions. Current EU law distinguishes between “new” chemicals
and “existing” chemicals. Existing chemicals were on the mar-
ket before September 1981 numbering more than 100,000 sub-
stances and over 99 percent of commercial chemicals in terms
of tonnage. 2 While existing EU Directives require that new sub-
stances are tested and their risks assessed, “existing” substances
are not subject to the same testing requirements. As a result, EU
law has not obtained basic screening data about the characteris-
tics and impacts of most chemicals. Without such information,
chemicals policy is blind to the risks posed by chemicals and
frozen into inaction.3
In addition to the general lack of knowledge about the prop-
erties and the uses of existing substances, current EU law on
chemicals suffers from other serious deficiencies. The duty to
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provide credible information about chemical safety falls on
authorities instead of the enterprises that make and sell chemi-
cals. The risk assessment process is slow and costly, allowing
continued production, marketing, and use of potentially danger-
ous chemicals. Further, the Commission is responsible for car-
rying out risk assessments and adequate cost/benefit analysis
prior to any regulatory proposal relating to marketing and use of
dangerous substances.4 Liability regimes are insufficient to
ensure redress for injured parties when cause and effect are dis-
tanced and if adequate data on the effects of chemicals are not
available. Finally, the EU’s current legal framework on chemi-
cals is a patchwork of Directives and Regulations that has been
characterized as a barrier to innovation by discouraging research
and favoring existing substances over new, safer chemicals. 
The European Union is
home to the 500 billion Euro
chemicals industry, the world’s
largest. As the source of a third
of global chemical production,
and with an educated and envi-
ronmentally aware citizenry,
Europe is at the center of the
contemporary struggle to recon-
cile its industrial economy with
protection of public health and
the environment. How REACH
is ultimately agreed and how it
is implemented will have
important implications for the
direction of international law
and the evolving role of the EU
as a leader internationally on
matters of health and environmental protection.
REACH’S BACKGROUND: EVOLUTION OF EU
CHEMICALS POLICY AND EU INSTITUTIONS
A comprehensive narrative of the EU’s reform of its chem-
icals framework would require extensive detail on the unprece-
dented and intense involvement of national governments, indus-
try, and civil society in a broad debate handled largely by EU
Institutions. Fortunately, up to 2004 that narrative can be found
elsewhere.5 This section provides a general overview of key
events and actors, with a view to contextualizing the interna-
tional law dimensions of REACH.
THE EVOLUTION OF EU CHEMICALS POLICY AND
REGIONAL AGREEMENTS
In the late 1960s, at a time of increased environmental
awareness, the first signs of what would later become a patch-
work legislation concerning chemicals began to surface. The
first EC legislative instrument on industrial chemicals was the
1967 Directive on Classification and Labelling of Chemicals,6
which focused on harmonizing trade in chemicals and protect-
ing workers from acute exposure, but did not require testing or
other data. Subsequently, the 1976 Directive on Restrictions of
Certain Substances7 was an attempt to harmonize chemicals pol-
icy in response to trade obstacles resulting from some Members
banning or restricting production or use of certain chemicals.
Under this Directive, the Commission committed itself to carry-
ing out risk assessments and cost/benefit analyses prior to any
proposal or adoption of a regulatory measure concerning chem-
icals. In 1979, an important amendment to the 1967 Directive
was adopted, establishing the “new” and “existing” distinction.8
In 1988, the Council replaced several directives concerning
preparations with the Directive on Classification and Labelling
on Preparations.9
By 1993, disparities in the national legislations implement-
ing the above-mentioned Directives and their impact on EC
trade, coupled with increasing awareness of the substantial
threat posed to human health and the environment by chemicals,
led to the 1993 Council Regula-
tion on Evaluation of Existing
Substances. According to this
regulation, certain categories of
data were to be provided to the
authorities. Progress on risk
assessment was slow, however,
and restrictions or bans could
only be adopted if the authority
could show strong evidence of
the substance’s negative effects.
This business-as-usual approach
ultimately proved unacceptable
to countries particularly affected
by persistent pollution. 
Meanwhile, regional agree-
ments were concluded to address
pollution issues. Nordic and
other countries such as Belgium, the Netherlands, the United
Kingdom, and Germany have taken a lead in efforts to protect
the marine environment of the North Sea, for example, includ-
ing the phase-out of hazardous chemicals. The North Sea
Conferences have produced political commitments which have
played an important role in influencing legally binding environ-
mental management decisions both nationally and within the
framework of competent international bodies. The 1995
Ministerial Declaration adopted in Esbjerg, Denmark stands as
a landmark in that it defines an operational objective: to cease
all releases to the marine environment of human-made and nat-
ural hazardous substances, in order to achieve background lev-
els of natural hazardous substances by 2020 (in one genera-
tion).10 Similar wording was adopted in June 2001 by the EU
Council to define the objectives of the new EU chemicals strat-
egy and by the 2006 Strategic Approach to International
Chemicals Management, adopted under the auspices of the
United Nations Environment Programme.11
This objective was also adopted by the 1992 Convention
for the Protection of the Marine Environment of the North-East
Atlantic (the “OSPAR Convention”) in its first meeting in
Sintra, Portugal in 1998.12 A review of its first five years expe-
rience in implementing activities to achieve the “one genera-
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REACH will ensure a
common playing field
within the EC internal
market, where all
chemical producers and
traders will be subject to
the same specific
requirements.
tion” goal led to the 2003 Hazardous Waste Strategy, which ulti-
mately aims to achieve “concentrations in the marine environ-
ment near background values for naturally occurring substances
and close to zero for manmade synthetic substances” by the year
2020.13 In order to achieve this objective, the OSPAR
Convention actively engaged EU institutions, contributing its
expertise to the EU chemicals policy reform process.
EU INSTITUTIONS AND THE
POLITICAL BATTLE OVER REACH
Against this broader international legal background, in
1998 environment ministers of EU Member States initiated
intensive public dialogue about chemicals, public health, and
the environment. In an informal meeting in Chester, UK, the
environment ministers concluded that a comprehensive review
of the system was necessary, with a view to introducing princi-
ples of sustainable development in the chemicals sector. The
Commission conducted this review in 1998, identifying major
weaknesses in the current chem-
icals legislation. The Council
welcomed the Commission’s
progress and requested it to
organize a brain-storming meet-
ing open to all relevant stake-
holders that could inform a pro-
posal. In February 2001, the
Commission presented its White
Paper on a Strategy for a Future
Chemicals Policy (REACH), a
prescient nickname for one of
the hardest fought political bat-
tles in Brussels. All this led to an
enormously contentious and
complex political debate with unprecedented participation by
NGOs, business, and others.
As the administrative branch of the EU, the European
Commission has particular responsibilities in preparing legisla-
tion proposals.14 In the ambit of REACH, DG-Environment and
DG-Enterprise were tasked to draft REACH together. The
Commission has attempted an inclusive process of debate to
address the complex issues associated with chemicals policy. In
2001, for example, after presenting its White Paper, the
Commission organized a stakeholder conference and convened
technical working groups. In May 2003, the entire draft regula-
tion was posted on the internet for consultation, which enabled
unprecedented participation by governments, industry, and a
range of civil society. On October 29, 2003, the Commission
sent its proposed REACH regulation to the Parliament. Since
then, the Commission has been actively involved in consultation
with Council and Parliament, and also managing a range of
implementation projects with authorities, industry, and others.
The European Parliament is the elected political body of the
EU, with a key role in the co-legislation process. Its Members
(“MEPs”) are elected in national elections and they are organized
by political groups.15 While the Parliament had a role during the
discussion of the White Paper, when after the draft entered
Parliament, it became the focus of intense committee debate
(2003-2005). The Environment Committee took the lead, in what
turned out to be a hard fought turf battle, and other committees
gave “opinions.” On November 17, 2005, Parliament adopted over
one thousand amendments to the draft in its first reading vote. The
Parliament has subsequently been involved in dialogue with
Council on the draft, and is expected to hold a second reading vote
in 2006.
The Council of the European Union represents the (now 25)
Member States of the European Union and organizes its work on
the basis of specialized topics, e.g. Environment Council,
Competitiveness Council, etc.16 This arrangement means that
the Council reflects national political influence, but is also
informed by technical experts from ministries, competent
authorities, etc. This arrangement has also had profound influ-
ence on the Council’s stance before REACH. In fact, while early
discussions on chemicals policy were steered by the
Environment Council, the draft REACH regulation was placed
under the competence of the
Competitiveness Council, which
led to greater emphasis on issues
of workability, innovation, and
implementation costs. The
Council also operates under the
leadership of a presidency that
sets the agenda on a rotating six-
month basis. This has had impli-
cations for REACH process, as
key decisions were made under
the Italian, Dutch, and other
presidencies. In December 2005
the Council reached a prelimi-
nary political agreement under the UK Presidency. After regular
deliberations on most major aspect of the 2003 draft regulation,
and after the 2005 preliminary political agreement, in February
2006 the Council adopted its “common position” regarding the
Parliament’s first reading vote, which essentially defines the
practical bounds for an eventual compromise.17 Any remaining
differences between the Council and Parliament’s second read-
ing vote would be resolved through a formal conciliation
process. REACH is now expected to enter into force in 2007.
REACH IN FOCUS: OBJECTIVES, REQUIREMENTS,
AND THE NEW EUROPEAN CHEMICALS AGENCY
As the previous section shows, REACH is the result of a
complex process, where multiple interests and players have
engaged in a vigorous and heated debate over the future of EU
chemicals policy. Given that REACH is still a live document
and that a final regulation is expected in 2007, rather than
attempting a comprehensive analysis of REACH, this section
will only discuss some of its general features and central
requirements, based on the Council’s Common Position and the
Parliament’s first reading vote.
OBJECTIVES OF REACH
The political objectives of the proposed strategy for a future
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Europe will feel the ripple
effects of REACH through
global supply chains and
evolving international
standards. 
chemicals policy prepared by the Commission encompassed a
range of important public policy goals. Pursuant to the challenge
of sustainable development, and within the framework of the EC
common market, REACH attempts to integrate environmental,
economic, and social considerations in the design of the pro-
posed chemicals strategy. As elaborated in the White Paper, the
political objectives of REACH include:
Protection of Human Health and Promotion of a Non-
toxic Environment
This objective requires a process for ensuring the safety of
tens of thousands of chemicals, especially “existing” substances
that have been held to a lower standard than new ones. This
process would distinguish substances according to proven or
suspected hazardous properties, uses, exposure, and volumes of
production or trade, in order to prioritize actions. Industry,
including companies along the manufacturing chain, would be
responsible for generating and assessing data and assessing the
risks of the use of the substances. Ultimately, this process would
fill the large data gap concerning chemical hazards and uses,
thereby enabling a sound chemicals policy for the protection of
human health and the environment.
Maintenance and Enhancement of the
Competitiveness of the EU Chemical Industry
Given the economic importance of the chemical industry in
the EU, including with respect to jobs, the White Paper encour-
aged innovation and in particular the development of safer
chemicals. In addition, a workable and realistic timetable for
submission of data, coupled with flexible test data and other
measures (e.g. testing thresholds) would limit the cost for enter-
prises. 
Prevention of Fragmentation of the Internal Market
The White Paper places considerable importance on the
internal market, following the Commission’s role as the steward
of the EC market. In this light, the White Paper views health and
environment protection as fully compatible with the proper
functioning of the internal market in the chemicals sector, as in
any other industrial sector within the Union. The White Paper
also proposes that to meet its objectives, the new chemicals pol-
icy be based on full harmonization.
Increased Transparency
Transparency in the White Paper is addressed from two
angles. First is the “public right to know;” that is, the public’s
right to access information about the chemicals to which they
are exposed. The economic implications of the public’s right to
know will center on the public’s ability to make informed choic-
es in the marketplace, avoiding dangerous products and prefer-
ring safer substitutes. The second angle relating to enhanced
transparency is institutional and administrative; a single system
applying to all chemicals will improve the transparency of the
regulation. 
Integration with International Aspects
This objective encompasses several dimensions, including
recognizing test results carried out using globally harmonized
methodology in order to reduce costs and animal testing; pre-
venting distortions to the global market by covering importers;
and supporting multilateral environmental initiatives relating to
chemical safety. In this latter vein, the White Paper supports
efforts by the OSPAR Convention, the Stockholm Persistent
Organic Pollutants Convention, and the Rotterdam Convention
on the Prior Informed Consent Procedure for Certain Hazardous
Chemicals and Pesticides in International Trade. This objective
also addresses the need to strengthen developing countries’
capabilities and capacities for managing chemicals. 
Promotion of Non-animal Testing
The White Paper recognized the difficulties and dilemmas
surfacing from the need to tests chemicals in different ways,
including on animals, in order to assess hazard and risk. This
objective seeks to reduce animal testing to an absolute minimum
by maximizing the use of existing non-animal test methods.
Also, this objective calls for the development of new non-ani-
mal test methods, as well as for careful definition of testing
thresholds, flexible test regimes, and sequencing in the produc-
tion of information.
Conformity with EU International Obligations under
the WTO
The White Paper is explicit about the WTO obligations con-
tained in the Agreement on Technical Barriers to Trade (“TBT
Agreement”) (addressed below). In particular, this objective
calls for preventing discrimination against imported products;
ensuring that its measures are based on sound scientific evalua-
tion of the potential threats to human health and the environ-
ment; and ensuring that its technical regulations do not create
unnecessary obstacles to international trade. 
The analysis of the objectives of REACH shows the close
linkages between the economic, public health, and environmen-
tal dimensions of chemicals management under the broader
umbrella framework of sustainable development. In this light,
REACH is redefining the different roles of the various social
actors involved in chemicals production and trade, and has
introduced a “duty of care” approach to chemicals production
and trade, where industry takes responsibility of the products
that it places on the market. This duty of care is complemented
by stringent requirements regarding information on chemicals,
summarized by the “no data, no market” quote. REACH’s
requirements also show a preference for safer substitutes (with-
out having to fully prove dangers) as a means to gradually
secure health as well as stimulate innovation. These require-
ments and other specific obligations contained in the REACH
regulation are examined next. 
REQUIREMENTS IN REACH
As a regulation, REACH is directly applicable to EU
Members States and enforceable in their domestic courts.
Among other things, this “harmonization” feature contrasts
REACH from the current EC Directives that concern chemicals,
which have been implemented by multiple and varying domes-
tic laws in Members. Thus, REACH will ensure a common play-
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ing field within the EC internal market, where all chemical pro-
ducers and traders will be subject to the same specific require-
ments. The central requirements of REACH are found in its
acronym: Registration, Evaluation, and Authorization, exam-
ined in cursory fashion below. 
Registration
Registration requires a manufacturer to notify an authority
of the intention to produce or import a substance and to submit
a dossier containing the information required by the legislation.
Registration will be obligatory for all chemicals produced or
imported in volumes exceeding one ton per year, including
“existing” and “new” chemicals. In general terms, unless other-
wise exempted, failure to register means that the substance will
not be allowed in the market.
The timing and amount of information required for regis-
tration depends partly on the volume produced or imported.
While risk of a chemical substance towards human health and
the environment is not necessar-
ily proportional to the volume of
production, volume is a proxy
for exposure, as it allows a clear,
enforceable priority setting for
registration which also gives
legal certainty.18 For substances
above one ton, a technical
dossier (containing information
on the properties, uses, classifi-
cation, and guidance on safe
use) must be submitted to the
authorities. For substances
above ten tons, a chemical safe-
ty report (“CSR”) is required. A
CSR documents the hazard clas-
sification of a substance and the
assessment as to whether the
substance is persistent, bioaccumulative and toxic (“PBT”) or
very persistent and very bioaccumulative (“vPvB”). Further, the
CSR also describes exposure scenarios, including appropriate
risk management measures, for all identified uses of dangerous,
PBT, and vPvB substances.19
REACH allows for, but does not require, chemical makers
and importers to share data for registration. There are also cost-
sharing provisions among registrants, designed to respect prop-
erty rights to data and to fairly allocate the cost of producing the
required information. New tests are only required when it is not
possible to provide the information in any other permitted way,
in order to minimize animal testing. In these situations, the man-
ufacturer or importer would submit proposals for testing, which
will be scrutinized by the authorities in the evaluation process
before the tests are performed. 
Evaluation
The evaluation process consists of an examination of the
data contained in the registration dossiers provided by industry.
There are two types of evaluation: dossier evaluation and sub-
stance evaluation. The dossier evaluation includes a (1) compli-
ance check (or completeness check), where authorities test the
registration dossiers against the registration requirements, and a
(2) checking of testing proposals, where authorities evaluate the
animal testing proposals to prevent repetition of existing tests
and poor quality tests. The substance evaluation focuses on sus-
picions of risks to human health or the environment and may
lead to requests for further information or expedited action. The
new chemicals agency will develop guidance on prioritization
of substances for evaluation. Evaluation may lead to the con-
clusion that further action needs to be explored under the
authorization procedures.
Authorization
An authorization is required for the use and marketing of
“substances of very high concern.” There are several categories
of such substances of very high concern, constructed on the
basis of their properties: (1) carcinogenic, mutagenic, or toxic
for reproduction; (2) PBTs or
vPvB; and (3) equivalent to the
above in their potential to cause
serious and irreversible effects to
humans or the environment, such
as endocrine disrupters. Autho-
rization under REACH could
include bans or restrictions on
the manufacture or uses of these
chemicals, but banning sub-
stances or uses will not occur by
default. Of the estimated 30,000
produced above one ton per year,
an estimated 1,500 chemicals
may require authorization. 
The authorization process
consists of two steps. The first
step focuses on identifying the
substances that will be included in the system; the uses that will
be exempted because of sufficient controls; and the deadlines
that will have to be met. The new Chemicals Agency will make
recommendations for priority substances for authorization based
largely on risk, i.e. use, volume, and properties, while taking
into account workability considerations. The second step
requires industry to apply for an authorization for each use,
demonstrating that either the risk of the use of the substance is
adequately controlled, or that the socio-economic benefits out-
weigh the risks, taking account of alternative substitutes. In
order to enable costs to be minimized, REACH allows groups of
applications for authorization, such as by manufacturers,
importers, and downstream users.
Registration, evaluation, and authorization are the support-
ing pillars of REACH’s new approach to chemical safety. A crit-
ical question that surfaces with respect to the operation of the
proposed REACH regulation is its scope, i.e. which substances
are covered by these requirements. In that context, it is impor-
tant to note that REACH only covers substances (chemicals) but
does not cover preparations. Additionally, REACH exempts
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REACH ultimately …
contributes to improving
public health and the
environment globally, and
in meeting Europe’s
commitment to the global
2020 goal for a toxic-free
future.
inter alia radioactive substances, wastes, non-isolated interme-
diates and substances that Members States deem necessary for
their defense interests.20
Yet another controversial aspect about REACH’s scope is
that it does not cover products.21 This exclusion, however, is not
absolute, and REACH may apply if certain conditions are pres-
ent, such as if chemicals in products are dangerous and intend-
ed to be released from the article during normal and reasonably
foreseeable conditions of use. While there is considerable uncer-
tainty in regard to the exact meaning of this language, the exclu-
sion of products (including imported products) represents a
shortcoming of the system to the extent that these products may
have been manufactured utilizing dangerous chemicals that
could be released unintentionally to the environment, thereby
threatening public health. Further, while release may not be
intended, there may be cases or products where it could never-
theless be foreseen that some of the chemicals employed in their
manufacture would be released to the environment. In such
cases where substances may be released incidentally to the use
of the article, a simple notification is required. From another
perspective, the exclusion of products from REACH means that
a plethora of difficult questions concerning WTO-consistency
are left for a future day. 
Another key question regarding the implementation of
REACH’s requirements concerns the timetable for registration.
REACH envisages a tiered approach for registration to be
phased in over eleven years, where deadlines hinge on produc-
tion volume, e.g. above one ton, one-hundred tons, one-thou-
sand tons, etc. At the same time, the system is expected to be
flexible enough to allow for earlier registration of substances of
concern, including those having proven or suspected hazardous
properties and those intended for consumer use. 
It is readily apparent that the requirements in REACH are
varied and complex.22 Several developing countries have com-
mented on the difficulties that their chemical producers and
exporters will face to maintain their market presence in the EC,
as discussed further below. In order to facilitate the implemen-
tation of the new chemicals regulation, the creation of a new
agency is envisaged, examined in turn. 
A NEW EUROPEAN CHEMICALS AGENCY
In order to administer REACH and facilitate its implemen-
tation, a new European Chemicals institution is being estab-
lished in Helsinki. The new Chemicals Agency is expected to
build on the Commission’s experience with other agencies in
other fields, in particular those working on medicinal products
and food safety. The agency is also expected to provide Member
State authorities with technical and scientific support, as well as
to coordinate the evaluation of substances by national environ-
mental authorities. The Chemical Agency has no enforcement
powers, and would rely on the Commission to enforce REACH. 
A key aspect of the new European chemicals agency con-
cerns its role with respect to information on chemicals. The cen-
tral chemicals entity will manage the registration process, serv-
ing as receiving body for the registration dossiers and forward-
ing copies of the dossiers to the Member State authorities. The
agency will also undertake compliance checks and evaluation of
testing proposals of the dossiers. The agency will maintain a
comprehensive central database on all registered chemicals, per-
forming computerized screening for properties raising particular
concern. Crucially, the new agency will provide access to non-
confidential information about chemicals to the general public,
thereby contributing to a better understanding of chemical safe-
ty to the public worldwide.
INTERNATIONAL LAW IMPLICATIONS OF REACH
REACH’s multifaceted characteristics mean that it links
with various dimensions of international law. By its own nature
as an EC Council Regulation, REACH is binding on EU
Member States, and directly applicable before their internal
courts. This argues for a detailed analysis of EU law, however,
this section explores some of REACH’s implications for inter-
national human rights law and trade law. 
HUMAN RIGHTS AND ENVIRONMENT DIMENSION
Under human rights law, States are under an obligation to
structure their legal systems in a way that ensures the free and
full exercise of fundamental rights, including the right to health.
In particular, international human rights law imposes upon
States the duty to take concrete steps towards the full realization
of the right to the highest attainable standards of physical and
mental health.23 More generally, the linkages between environ-
mental health and human rights have been clarified by the work
of UN Special Rapporteurs24 and recognized by a number of
international instruments.25
Further, States are under a positive duty to take reasonable
and appropriate measures to secure certain civil and political
rights particularly affected by pollution.26 The European Court
of Human Rights (“ECHR”) in Fadeyeva v. Russia observed
that the State’s responsibility in environmental cases may arise
from a failure to regulate private industry, and inquired whether
the State could reasonably be expected to act so as to prevent or
put an end to the infringement of the applicant’s rights.27 In
Oneryildiz v. Turkey, the Grand Chamber of the ECHR further
elaborated on the positive obligation to take all appropriate steps
to safeguard life, including the duty to put in place a legislative
and administrative framework. In the words of the Court, “This
obligation indisputably applies in the particular context of dan-
gerous activities, where, in addition, special emphasis must be
placed on regulations geared to the special features of the activ-
ity in question, particularly with regard to the level of the poten-
tial risk to human lives.” 28
When viewed under a human rights and environment lens,
REACH could represent (when completed and depending on the
final outcome) a concrete step towards the realization of the
right to health. This is important for the advancement of eco-
nomic, social, and cultural rights, as well as for the protection of
civil and political rights enshrined in the European Convention
on Human Rights. In addition, in light of the persistence and
long-range travel potential of certain chemicals and given the
volumes of chemicals produced in the EU, REACH ultimately
also contributes to improving public health and the environment
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globally, and in meeting Europe’s commitment to the global
2020 goal for a toxic-free future. 
REACH AND THE INTERNATIONAL TRADING SYSTEM
Conformance with international trade law was an explicit
consideration in the crafting of REACH. While the draft legis-
lation was engineered by DG-Enterprise and DG-Environment,
they deferred to DG-Trade on ways to steer clear of WTO vio-
lations. The treatment of substances in articles (i.e. chemicals in
products) examined above illustrates the influence of trade law
in REACH design. As noted earlier, the European Commission
conducted a novel and broad Internet consultation in 2003 to
hear concerns, including on trade. 
On its part, the Bush administration worked with the U.S.
chemical industry to undermine REACH, as a House
Committee report describes.29 The administration said publicly
that REACH would threaten $20 billion in U.S. chemicals
exported to the EU. The House Committee report also contains
references to cables sent in March 2002 and April 2003 by U.S.
Secretary of State Colin Powell to U.S. trading partners in Latin
America and Asia as well as Europe to oppose REACH. It may
be that some of the submissions to the WTO, presented below,
are the result of the U.S. campaign against REACH. Further, the
U.S. Department of Commerce developed an extensive outreach
plan to influence “stakeholders” within the European Union and
generate opposition to REACH, and also targeted countries of
the Asia-Pacific Economic Cooperation (“APEC”).30
In January 2004, in accordance with the WTO’s TBT
Agreement, the EU notified REACH to the WTO’s Committee
of Technical Barriers to Trade (“TBT Committee”).31 WTO
Members raised a number of issues relating to the compatibility
of REACH and the TBT Agreement, including questions con-
cerning national treatment, unnecessary obstacles to trade, inter-
national standards, and special and differentiated treatment for
developing countries. Some countries also mentioned concerns
with respect to intellectual property rights and the treatment of
confidential information in REACH. This section provides an
overview of the relevant TBT issues identified in these submis-
sions to the TBT Committee, with a view to identifying the
potential claims in a possible WTO challenge to REACH by the
United States or other nations. 
National Treatment
The TBT Agreement provides that the WTO Members shall
ensure that their technical regulations do not accord products
imported from other Members with less favorable treatment
than those accorded to like products of national origin.32 WTO
Members generally pointed out that REACH is more difficult
for non-EU manufacturers to comply than for EU manufactur-
ers, which leads to de facto discrimination.33 Singapore elabo-
rated on the de facto discriminatory effects by noting that due to
long distance and unfamiliarity with REACH, non-EU produc-
ers and suppliers will face more hardship than EU producers to
comply with REACH. Thailand also raised concerns about
REACH’s data sharing provisions (which allow the first regis-
trant to charge 50 percent of the cost from subsequent regis-
trants),34 noting that such a scheme favors EU producers
because they will likely register early and then charge subse-
quent non-EU registrants.35
Unnecessary Obstacles to International Trade
Under the TBT Agreement, technical regulations shall not
be prepared, adopted, or applied to create unnecessary obstacles
to international trade, and regulations shall not be more trade-
restrictive than necessary to fulfill a legitimate purpose.36 To
some degree, every comment submitted to the TBT Committee
regarding REACH raised concerns about unnecessary obstacles
to international trade. The high costs associated with implemen-
tation and compliance, it was argued, would drive many com-
petitors out of business, especially small and medium enterpris-
es in developing countries. Some commented that the scope of
REACH was broader than any OECD country, imposing admin-
istrative burdens on many substances that may pose negligible
risk to health and the environment. Several countries comment-
ed that the hazard-based and volume-based approaches in
REACH were incompatible with a scientific, risk-based evalua-
tion of substances.37 Finally, several WTO Members claimed
that REACH did not recognize test results generated outside the
EU, even where such data was obtained in conformity with the
OECD Principles of Good Laboratory Practice, increasing com-
pliance costs, frustrating cooperation, and imposing unneces-
sary obstacles to trade.38
Relevant International Standards
The TBT Agreement requires that Members use relevant
international standards that exist unless such standards would
be an ineffective or inappropriate means for the fulfillment of
the legitimate objectives pursued.39 This provision was direct-
ly at issue in EC – Sardines, where the Appellate Body held
that where a Member departs from a relevant international
standard because it considers it to be ineffective to achieve its
legitimate objectives, the burden of proof will nevertheless
fall on the complaining Member.40 It is of course open to
question whether existing international standards exist to
achieve the goals of REACH. Several comments charged that
REACH was incompatible with international efforts to con-
trol chemicals, such as the OECD High Production Volume
(“HPV”) initiative or the Globally Harmonized System
(“GHS”) for classification and labeling.41
Special and Differential Treatment for Developing
Countries
The TBT Agreement requires that in the preparation and
application of technical regulations, Members take into account
the special developmental, financial, and trade needs of devel-
oping country Members, with a view to ensuring that such tech-
nical regulations, standards, and conformity assessment proce-
dures do not create unnecessary obstacles to exports from those
Members.42 Interpreting a similarly worded provision in the
WTO Agreement on Sanitary and Phitosanitary Measures, the
EC-Biotech Panel noted that “taking into account” does not pre-
scribe a specific result to be achieved, and that in weighing and
balancing the various interests at stake, the needs of a develop-
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ing country did not have priority over, for instance, other legiti-
mate interests.43 The TBT Agreement also provides that the
Member imposing technical regulations shall take reasonable
measures to arrange for the regulatory bodies to advise other
members, grant them technical assistance on mutually agreed
terms and conditions.44
Brazil, China, Cuba, and Thailand raised particular concerns
about REACH and these provisions of the TBT Agreement, not-
ing that advice and technical assistance were necessary, includ-
ing by way of implementation guidance by sectors.45
NEXT STEPS
At the time of writing, the Council has been discussing the
Parliament’s November 17, 2005 vote. The Council struck a
political agreement on Dec. 13, 2005 under the UK
Presidency. A Common Position was approved in February
2006 reflecting some of the Parliament’s first reading. The
Parliament will take up the Council’s draft in second reading
in May or June 2006. The Parliament can then either accept the
Council’s amendments or pass certain amendments for consid-
eration in the formal conciliation process. In the international
sphere, the comments submitted to the TBT Committee may
prelude a brewing trade challenge to certain measures adopted
pursuant to REACH. 
CONCLUSION
REACH is coming. After years of dialogue, debate and
bruising politics, the EU has created a new model for regulating
chemicals. Did the EU over-reach? Will the final compromises
so weaken the system that few health benefits will result? Will
REACH lead the world toward greener chemistry or burden EU
producers and outsource pollution elsewhere?
REACH is motivated by a desire to eliminate substances
that negatively impact on human health and its underlying deter-
minants, including the environment. But this first requires an
adequate understanding of the basic characteristics of chemicals
– something that is impossible with the current level of knowl-
edge and built-in incentives. By ensuring that much of this
information on chemicals will be made publicly available, it is
likely that governments, companies, and civil society beyond
the EU will benefit as well.
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has threatened to bring a WTO challenge against the EU if the
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CONCLUSION
For the near term, it appears that the EU will continue to set
the pace when it comes to product-based environmental regula-
tion. In the United States, it seems likely that an increasing num-
ber of state legislatures and even members of Congress will take
a closer look at Europe’s new emphasis on regulating products.
Other countries outside of Europe, most notably the People’s
Republic of China, are also following the EU approach by
adopting their own product-based environmental requirements.
Whether these new national and sub-national initiatives gravi-
tate toward harmonized product standards or instead evolve into
a patchwork of competing mandates that undermine internation-
al trade remains one of the most important environmental and
economic policy questions of the next decade. 
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